Dr. Michael J. Crimmins, MD

Dr. Crimmins practices at HCA Florida Mercy Hospital in Miami, Florida.

Dr. Crimmins' NPI, 1689830564, was assigned on July 31, 2008. Dr. Crimmins graduated from University of Maryland School of Medicine - Baltimore in 2008. Dr. Crimmins holds Florida license ME156779.

Dr. Crimmins' primary practice is HCA Florida Mercy Hospital, at 3663 S Miami Ave, Miami, FL 33133 in Miami-Dade County. The practice phone is (305) 285-2121.

Dr. Crimmins' primary practice is HCA Florida Mercy Hospital in Miami, Florida. Dr. Crimmins is also affiliated with HCA Florida Mercy Hospital. The medical group on file is Sentara Medical Group. Dmand AI also links Dr. Crimmins to 4 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crimmins practices, 5 sites in all. Vendor and product names are available with a free account.

Neurocritical care is Dr. Crimmins' primary specialty in the NPI Registry, under taxonomy code 2084A2900X. Dr. Crimmins is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Crimmins' licenses on file in 7 states: Florida, South Dakota, Virginia, Maryland, North Carolina, Ohio and New York.

Dmand AI lists cerebrovascular disease among the conditions Dr. Crimmins treats.

CMS data shows 301 Medicare services from Dr. Crimmins across 6 procedure codes in 2024, for 153 Medicare patients. Medicare paid $39,801 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Crimmins in 2024. The largest group is 85 and over, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crimmins' median patient age at 74, with 60% women.

In 2024, Dr. Crimmins wrote 34 Medicare Part D claims for 18 patients. 50% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $8,542 in total drug cost.

Dr. Crimmins accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Crimmins as offering telehealth.

Dmand AI links 6 papers to Dr. Crimmins, published from 2013 to 2021. The most frequent topics are Subarachnoid Hemorrhage, Brain Ischemia and Electrocardiography. Dr. Crimmins has published most often in Neurocrit Care. Dr. Crimmins' most frequent co-authors are Jan Claassen, MD, Krishna Amuluru, MD and Brian Patrick Curry, MD.

CMS Open Payments shows 93 general payments to Dr. Crimmins from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Penumbra, Inc. paid the most, $1,498.

Dmand AI lists 1 award for Dr. Crimmins, most recently Hallenback Award for Top Neurology Resident in 2012.

Dr. Crimmins graduated from University of Maryland School of Medicine - Baltimore in 2008.

Dr. Crimmins is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.